
‘We thought we'd got the numbers wrong': Holloman Lake is a birder's paradise – and has the highest levels of ‘forever chemicals' on record
The lake – created in 1965 as part of a system of wastewater catchment ponds for Holloman air force base – is an unlikely oasis. Other than small ponds created for livestock it is the only body of water for thousands of square kilometres in an otherwise stark landscape. However, Witt says there was always something slightly weird about the foam that would form around the edge. 'But I only saw that stuff once I knew.'
Few people live around here, but those that do enjoyed the lake. Online it was billed as a 'free, no-frills experience' for camping. On weekends, up to 20 people could be seen pitching tents and barbecuing on the southern shore.
In 2009, plans were drawn up to construct a pavilion, beach area and nature trails to encourage more people to enjoy the area. But all that changed in 2017 when authorities discovered what was in the water.
Since then an alarming picture has been building up of the extent of the chemical contamination at Holloman Lake. Last month, research co-authored by Witt showed the site has the highest Pfas concentration in water and plants ever recorded in peer-reviewed literature. Every part of the ecosystem is saturated in these 'forever chemicals', including the soil, algae, invertebrates, fish and reptiles.
Pfas, which stands for 'per- and polyfluoroalkyl substances', are a group of thousands of human-made chemicals prized for their water, heat and grease-resistant properties. The same attributes that make them so useful in industrial and consumer products are what make them so bad when they leak into the environment, where they can persist for hundreds of years.
Witt's birdwatching spot turned into a 'natural field laboratory' for understanding how forever chemicals affect ecosystems. He stopped going there for the pleasure of watching birds, and shifted to studying the area in his capacity as a professor of biology at the University of New Mexico. 'Honestly, I try not to spend too much time there,' he says. 'You can take up some of these Pfas compounds through skin contact, and you can breathe them in through the air and dust.'
When the Pfas results came back from the lab, Witt assumed it was a mistake. 'There were no other analogs that we could find for this level of contamination,' he says. 'The orders of magnitude that we were dealing with were absolutely shocking. We thought we were doing something wrong with the converssion of units.'
But the numbers were correct. Across 23 bird and mammal species tested, Pfas concentrations averaged tens of thousands of parts per billion, 2024 research found. For comparison, in 2019 thousands of dairy cows in Clovis, New Mexico were culled because their milk was contaminated with less than six parts per billion.
The main cause of contamination is the firefighting foams used in training exercises by the US air force at the Holloman site from about 1970. The single most contaminated individual from the 2024 study was a 1994 specimen of a white-footed mouse, showing pollution had been high for decades.
A dead killdeer chick was found by its nest on the ground near the lake. It was sent to the lab for testing, and its tissues had the highest Pfas concentration recorded to date in a bird, according to the 2025 paper.
The revelations about Pfas in the lake water triggered lawsuits from New Mexico's Environment Department against the military. In the US there are more than 9,000 active legal cases related to the production or release of Pfas.
But for Witt and other researchers on the ground, the scientific investigation was just beginning. He describes the state of current research as a 'hodgepodge of surveys here and there', all saying that we still don't know enough about how Pfas are moving through food webs globally, and how they could be affecting wildlife.
Now, the body of evidence of the impact of Pfas on wildlife is growing.
In Michigan, bluegill fish have been found to swim more slowly after Pfas exposure, suggesting they could be physically or neurologically impaired. Exposed black-legged kittiwakes are developing thyroid dysfunctions and hormonal imbalances. Sea turtles in contaminated sites in Australia are producing hatchlings with deformed scales and health problems. American alligators in North Carolina are more susceptible to infections, while dolphins in South Carolina are showing signs of chronic inflammation.
More than 600 species on every continent are at risk of harm, according to a map by the Environmental Working Group (EWG) illustrating how harmful chemicals are filtering through ecosystems. When they began mapping the research, 'we thought: 'it'll be a quick one month project' – then you quickly realise there are hundreds and hundreds of studies,' says David Andrews, acting chief science officer at EWG. 'It turned out to be a significant amount of work.'
It is likely that these chemicals are an additional stressor threatening species, along with climate breakdown and habitat loss. 'Nothing really escapes these chemicals – this is not something you can fly away from,' says Andrews.
Health impacts in humans, such as cancers, hormonal disruption and immune system disruption, are increasingly well documented. Research shows there are parallels in wildlife. 'What we see is an overlapping pattern of health harm between both humans and the wildlife species that have been studied,' says Andrews. As sampling becomes cheaper and more accessible around the globe and more testing is done, the map of Pfas in wildlife will continue to expand, he says.
The buildup of Pfas in wildlife also raises questions for those who hunt or consume wild meat. At Holloman Lake, even a single gram of duck meat would be too toxic to safely eat, based on average Pfas concentrations. Yet this is still a popular area for hunting.
Researchers are testing 400 ducks across the state to work out whether contaminants are jumping from hotspots such as Holloman to other wetlands. The preliminary results are 'concerning', says Witt, showing widespread contamination. That could be because ducks from sites such as Holloman are spreading it, or because there are other contaminated sites across the US, or some combination of the two. 'When you are eating wild duck meat, probably anywhere in North America, you're kind of rolling the dice,' he says.
Now, instead of watching birds, Witt is blending in with hunters in camo, capturing ducks and other birds and mammals to test their bodies for Pfas. 'I have really conflicted feelings about it; it's a beautiful place, it's so biodiverse, and yet really troubled,' says Witt. 'I feel a sense of urgency to figure out what is happening to the birds that are there.'
Find more age of extinction coverage here, and follow the biodiversity reporters Phoebe Weston and Patrick Greenfield in the Guardian app for more nature coverage.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
5 hours ago
- Reuters
Roche to test if new drug can prevent Alzheimer's disease, Bloomberg News reports
July 27 (Reuters) - Swiss drugmaker Roche Holding (ROG.S), opens new tab plans to test whether an experimental medicine can prevent Alzheimer's disease symptoms in high-risk people, Bloomberg News reported on Sunday. The new late-stage study will target people who are at risk of cognitive decline and aim to slow down the emergence of symptoms or prevent them fully, the report said, citing a statement. The new pre-clinical study is the third largest late-stage trial that the company has announced for its drug trontinemab, which uses an experimental technology called brain shuttle to ferry medicine past the protective blood-brain barrier, according to the report. Rivals like Eli Lilly (LLY.N), opens new tab have been making progress in the complicated field of Alzheimer's recently with Lilly's Alzheimer's drug Kisunla getting recommendation from the European Medicines Agency (EMA) last week. Reuters could not immediately verify the report. Roche did not immediately respond to a request for a comment. Treatments for Alzheimer's approved so far, including Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Leqembi, and Eli Lilly's Kisunla, are designed to clear sticky clumps of a protein called amyloid beta in the brain. They also carry hefty price tags and the risk of serious brain swelling and bleeding.


The Independent
9 hours ago
- The Independent
‘Fantastic Four: First Steps' scores Marvel's first $100 million box office opening of 2025
Marvel's first family has finally found box office gold. 'The Fantastic Four: First Steps,' the first film about the superheroes made under the guidance of Kevin Feige and the Walt Disney Co., earned $118 million in its first weekend in 4,125 North American theaters, according to studio estimates Sunday. That makes it the fourth biggest opening of the year, behind 'A Minecraft Movie,' 'Lilo & Stitch' and 'Superman,' and the biggest Marvel opening since 'Deadpool & Wolverine' grossed $211 million out of the gate last summer. Internationally, 'Fantastic Four' made $100 million from 52 territories, adding up to a $218 million worldwide debut. The numbers were within the range the studio was expecting. The film arrived in the wake of another big superhero reboot, James Gunn's 'Superman,' which opened three weekends ago and has already crossed $500 million globally. That film, from the other main player in comic book films, DC Studios, took second place with $24.9 million domestically. 'First Steps' is the latest attempt at bringing the superhuman family to the big screen, following lackluster performances for other versions. The film, based on the original Marvel comics, is set during the 1960s in a retro-futuristic world led by the Fantastic Four, a family of astronauts-turned-superhuman from exposure to cosmic rays during a space mission. The family is made up of Reed Richards (Pedro Pascal), who can stretch his body to incredible lengths; Sue Storm (Vanessa Kirby), who can render herself invisible; Johnny Storm (Joseph Quinn), who transforms into a fiery human torch; and Ben Grimm (Ebon Moss-Bachrach), who possesses tremendous superhuman strength with his stone-like flesh. The movie takes place four years after the family gained powers, during which Reed's inventions have transformed technology, and Sue's diplomacy has led to global peace. Both audiences and critics responded positively to the film, which currently has an 88% on Rotten Tomatoes and promising exit poll responses from opening weekend ticket buyers. An estimated 46% of audiences chose to see it on premium screens, including IMAX and other large formats. The once towering Marvel is working to rebuild audience enthusiasm for its films and characters. Its two previous offerings this year did not reach the cosmic box office heights of 'Deadpool & Wolverine," which made over $1.3 billion, or those of the 'Avengers'-era. But critically, the films have been on an upswing since the poorly reviewed 'Captain America: Brave New World,' which ultimately grossed $415 million worldwide. ' Thunderbolts," which jumpstarted the summer movie season, was better received critically but financially is capping out at just over $382 million globally. Like Deadpool and Wolverine, the Fantastic Four characters had been under the banner of 20th Century Fox for years. The studio produced two critically loathed, but decently profitable attempts in the mid-2000s with future Captain America Chris Evans as the Human Torch. In 2015, it tried again (unsuccessfully) with Michael B. Jordan and Miles Teller. They got another chance after Disney's $71 billion acquisition of Fox's entertainment assets in 2019. Top 10 movies by domestic box office With final domestic figures being released Monday, this list factors in the estimated ticket sales for Friday through Sunday at U.S. and Canadian theaters, according to Comscore: 1. 'The Fantastic Four: First Steps,' $118 million. 2. 'Superman,' $24.9 million. 3. 'Jurassic World Rebirth,' $13 million. 4. 'F1: The Movie,' $6.2 million. 5. 'Smurfs,' $5.4 million. 6. 'I Know What You Did Last Summer,' $5.1 million. 7. 'How to Train Your Dragon,' $2.8 million. 8. 'Eddington,' $1.7 million. 9. 'Saiyaara,' $1.3 million. 10. 'Oh, Hi!,' $1.1 million.


The Independent
9 hours ago
- The Independent
This fuzzy animal friend may be the key to treating schizophrenia
Llamas – likely without red pajamas – may hold the key to treating schizophrenia. The serious brain disorder causes people to interpret reality abnormally, and affects approximately 3.7 million U.S. adults between the ages of 18 to 65 years old, according to the nonprofit RTI International. But the domesticated South American woolly animal might be be able to help. French researchers said this week that they had used llama antibodies, or proteins that help to protect the immune system, to design a tiny fragment of an antibody known as a 'nanobody' that will trigger a neurotransmitter in the brain involved in regulating neural activity. Neurotransmitters are chemical molecules that carry messages or signals from one nerve cell to the next target cell, according to the Cleveland Clinic. No llamas were harmed in the study and researchers can identify nanobodies in a petri dish. In the past, llama antibodies have also proven effective in fighting Covid and other 'SARS-like' viruses. When scientists at the Institute of Functional Genomics injected the molecule into the veins or the muscles, it was able to break the blood-brain barrier and effectively reach brain receptors. The barrier is a a tightly locked layer of cells that defend your brain from harmful substances. Studying the impact of the nanobodies in two tests using mice, the researchers found that they corrected cognitive deficits that were observed. There was an improvement of cognitive function with just one shot, and a prolonged effect over one week. Clinical studies are now required to show that their findings could be a new avenue of treatment for schizophrenia. "In humans obviously we don't know [yet], but in mice yes, it is sufficient to treat most deficits of schizophrenia," molecular biologist Jean-Philippe Pin told Newsweek.. He was a co-author of the research which was published in the journal Nature. Pin said that medications currently given to schizophrenia patients "treat the symptoms well, but less the cognitive deficits." The cause of the chronic condition remains unknown, but the World Health Organization says it is thought that an interaction between genes and a range of environmental factors may be the reason. The exact prevalence of schizophrenia is difficult to measure. Some have tied cases in Canada to cannabis use. Although schizophrenia can occur at any age, people are typically diagnosed between the ages of 16 and 30. Symptoms vary from person to person. There is no cure, but it can be treated through antipsychotic medications, talk therapy, and self-management strategies, the National Alliance on Mental Illness says. The study's authors hope to add this strategy to the list. 'This research confirms the potential of nanobodies as a new therapeutic strategy for acting on the brain, with their use eventually being broadened to include the treatment of other neurological illnesses,' the institute said in a statement.